What is Universal Ibogaine Inc.'s annual revenue?

Universal Ibogaine Inc. (IBOGF) reported annual revenue of $1.0M in its most recent fiscal year.

What is Universal Ibogaine Inc.'s net profit?

Universal Ibogaine Inc. (IBOGF) reported a net loss of $10.0M in its most recent fiscal year.

What is IBOGF EV/EBITDA?

Universal Ibogaine Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.56. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

OTC · Financial Statements

Universal Ibogaine Inc. (IBOGF) Financial Statements

$0.02 OTC: IBOGF Market Cap $7.35M

Universal Ibogaine Inc. most recently reported annual revenue of $1.0M, a net loss of $10.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric	2018	2019	2020	2021	2022
Revenue	$0	$0	$0	$0	$1.0M
Operating Profit	$0	$0	$0	$-4.0M	$0
Net Profit	$0	$0	$0	$-4.0M	$-10.0M
EPS	$-0.04	$-0.01	$-0.01	$-0.03	$-0.06
Op Margin	—	—	—	—	46.4%

Balance Sheet (USD)

Metric	2018	2019	2020	2021	2022
Total Assets	$0	$0	$0	$4.0M	$6.0M
Total Liabilities	$0	$0	$0	$1.0M	$2.0M
Cash	$0	$0	$0	$0	$1.0M
Borrowings	$0	$0	$0	$0	$2.0M

Cash Flow (USD)

Metric	2018	2019	2020	2021	2022
Operating Cash Flow	$0	$0	$0	$-3.0M	$-4.0M
Investing Cash Flow	$0	$0	$0	$0	$-2.0M
Financing Cash Flow	$0	$0	$0	$1.0M	$1.0M
Net Cash Flow	$0	$0	$0	$0	$1.0M
Free Cash Flow	$0	$0	$0	$-3.0M	$-4.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.56
FCF Yield	-283.12%
Quick Ratio	1.60
Interest Coverage	7.34
Return 1Y	11.39%
Return 3Y	150.00%
Return 5Y	—

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

IBOGF Overview IBOGF Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.